Aileron Therapeutics Inc (ALRN)
3.37
-0.20
(-5.60%)
USD |
NASDAQ |
Nov 14, 12:34
Aileron Therapeutics Enterprise Value: 55.43M for Nov. 13, 2024
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| November 13, 2024 | 55.43M |
| November 12, 2024 | 61.06M |
| November 11, 2024 | 55.86M |
| November 08, 2024 | 60.41M |
| November 07, 2024 | 58.68M |
| November 06, 2024 | 61.28M |
| November 05, 2024 | 63.23M |
| November 04, 2024 | 64.75M |
| November 01, 2024 | 64.75M |
| October 31, 2024 | 67.35M |
| October 30, 2024 | 61.50M |
| October 29, 2024 | 66.48M |
| October 28, 2024 | 65.18M |
| October 25, 2024 | 58.57M |
| October 24, 2024 | 58.68M |
| October 23, 2024 | 55.32M |
| October 22, 2024 | 57.60M |
| October 21, 2024 | 55.43M |
| October 18, 2024 | 56.51M |
| October 17, 2024 | 56.30M |
| October 16, 2024 | 58.25M |
| October 15, 2024 | 58.03M |
| October 14, 2024 | 55.86M |
| October 11, 2024 | 56.51M |
| October 10, 2024 | 51.75M |
| Date | Value |
|---|---|
| October 09, 2024 | 53.05M |
| October 08, 2024 | 52.61M |
| October 07, 2024 | 48.93M |
| October 04, 2024 | 55.00M |
| October 03, 2024 | 53.05M |
| October 02, 2024 | 50.23M |
| October 01, 2024 | 56.51M |
| September 30, 2024 | 54.78M |
| September 27, 2024 | 57.16M |
| September 26, 2024 | 55.86M |
| September 25, 2024 | 47.63M |
| September 24, 2024 | 50.88M |
| September 23, 2024 | 58.46M |
| September 20, 2024 | 58.90M |
| September 19, 2024 | 41.13M |
| September 18, 2024 | 35.50M |
| September 17, 2024 | 40.48M |
| September 16, 2024 | 38.53M |
| September 13, 2024 | 37.45M |
| September 12, 2024 | 40.05M |
| September 11, 2024 | 40.48M |
| September 10, 2024 | 37.45M |
| September 09, 2024 | 37.66M |
| September 06, 2024 | 38.75M |
| September 05, 2024 | 40.70M |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
-19.67M
Minimum
Aug 02 2022
172.20M
Maximum
Jan 25 2021
19.51M
Average
4.041M
Median
Enterprise Value Benchmarks
| NovaBay Pharmaceuticals Inc | 3.432M |
| Palatin Technologies Inc | 13.74M |
| iBio Inc | 6.814M |
| Theriva Biologics Inc | -13.26M |
| Oragenics Inc | 2.142M |
Enterprise Value Related Metrics
| Net Income (Quarterly) | -8.942M |
| Total Expenses (Quarterly) | 9.039M |
| EPS Diluted (Quarterly) | -0.45 |
| Earnings Yield | -97.33% |